PL3632917T3 - Sposób wytwarzania pochodnych heterocyklicznych - Google Patents

Sposób wytwarzania pochodnych heterocyklicznych

Info

Publication number: PL3632917T3
Authority: PL; Poland
Prior art keywords: heterocyclic derivative; preparing heterocyclic; preparing; derivative; heterocyclic
Prior art date: 2017-05-25

Application number

PL18806513T

Other languages

English (en)

Inventor

Do Kyu Pyun

Kyoung Jin Oo

Original Assignee

Jw Pharmaceutical Corporation

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2017-05-25

Filing date

2018-05-24

Publication date

2022-04-11

2018-05-24 Application filed by Jw Pharmaceutical Corporation filed Critical Jw Pharmaceutical Corporation

2022-04-11 Publication of PL3632917T3 publication Critical patent/PL3632917T3/pl

Links

125000000623 heterocyclic group Chemical group 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C63/00—Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings
- C07C63/04—Monocyclic monocarboxylic acids
- C07C63/06—Benzoic acid
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C63/00—Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings
- C07C63/04—Monocyclic monocarboxylic acids
- C07C63/06—Benzoic acid
- C07C63/10—Halides thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/96—Esters of carbonic or haloformic acids
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Physical Education & Sports Medicine (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Medicinal Preparation (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Plural Heterocyclic Compounds (AREA)

PL18806513T 2017-05-25 2018-05-24 Sposób wytwarzania pochodnych heterocyklicznych PL3632917T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
KR20170064914		2017-05-25
PCT/KR2018/005932 WO2018217050A1 (ko)	2017-05-25	2018-05-24	헤테로사이클 유도체 화합물의 제조방법, 상기 화합물을 포함하는 조성물 및 상기 화합물의 수화물
EP18806513.0A EP3632917B1 (en)	2017-05-25	2018-05-24	Method for preparing heterocyclic derivative

Publications (1)

Publication Number	Publication Date
PL3632917T3 true PL3632917T3 (pl)	2022-04-11

Family

ID=64396846

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
PL18806513T PL3632917T3 (pl)	2017-05-25	2018-05-24	Sposób wytwarzania pochodnych heterocyklicznych
PL21180717.7T PL3909956T3 (pl)	2017-05-25	2018-05-24	1,5-Hydrat soli chlorowodorkowej pochodnej heterocyklicznej

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
PL21180717.7T PL3909956T3 (pl)	2017-05-25	2018-05-24	1,5-Hydrat soli chlorowodorkowej pochodnej heterocyklicznej

Country Status (25)

Country	Link
US (6)	US20200207784A1 (pl)
EP (3)	EP3632917B1 (pl)
JP (4)	JP2020521007A (pl)
KR (1)	KR102307504B1 (pl)
CN (3)	CN110691783A (pl)
AU (1)	AU2018273020B2 (pl)
CA (2)	CA3150710C (pl)
DK (1)	DK3909956T3 (pl)
EA (1)	EA201992801A1 (pl)
ES (2)	ES2907590T3 (pl)
FI (1)	FI3909956T3 (pl)
HR (1)	HRP20250183T1 (pl)
HU (1)	HUE070148T2 (pl)
IL (2)	IL294127B2 (pl)
LT (1)	LT3909956T (pl)
MX (2)	MX393863B (pl)
MY (1)	MY201054A (pl)
NZ (2)	NZ758513A (pl)
PH (1)	PH12019502418B1 (pl)
PL (2)	PL3632917T3 (pl)
PT (1)	PT3909956T (pl)
SI (1)	SI3909956T1 (pl)
TW (2)	TWI837089B (pl)
WO (1)	WO2018217050A1 (pl)
ZA (1)	ZA201908433B (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2021087836A (ja) *	2021-03-01	2021-06-10	株式会社三洋物産	遊技機
JP2021079225A (ja) *	2021-03-01	2021-05-27	株式会社三洋物産	遊技機
JP7556433B2 (ja) *	2022-08-22	2024-09-26	株式会社三洋物産	遊技機
JP7556432B2 (ja) *	2022-08-22	2024-09-26	株式会社三洋物産	遊技機
JP7556434B2 (ja) *	2022-08-22	2024-09-26	株式会社三洋物産	遊技機

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS6197291A (ja) *	1984-10-17	1986-05-15	Yamanouchi Pharmaceut Co Ltd	７−〔α−（２−アミノ−４−チアゾリル）−α−（低級アルコキシイミノ）アセトアミド〕−３−〔６−（２Ｈ−ピリド〔４，３−ｂ〕−１，４−オキサジニオ）メチル〕−Δ３−セフエム−４−カルボキシレ−トおよびその製造法
IL119466A (en)	1995-11-03	2001-08-26	Akzo Nobel Nv	Thrombin inhibitors, their preparation and pharmaceutical compositions containing them
AR051780A1 (es) *	2004-11-29	2007-02-07	Japan Tobacco Inc	Compuestos en anillo fusionados que contienen nitrogeno y utilizacion de los mismos
JP3988832B2 (ja) *	2004-11-29	2007-10-10	日本たばこ産業株式会社	窒素含有縮合環化合物及びその用途
JP4646068B2 (ja) *	2005-09-30	2011-03-09	国立大学法人東京工業大学	ポジ型感光性樹脂組成物、その製造方法、及びレリーフパターンの形成方法
US20080305169A1 (en) *	2006-05-26	2008-12-11	Japan Tobacco Inc.	Pharmaceutical Compositions Comprising Nitrogen-Containing Fused Ring Coumpounds
US20080064871A1 (en) *	2006-05-26	2008-03-13	Japan Tobacco Inc.	Production Method of Nitrogen-Containing Fused Ring Compounds
WO2008062740A1 (fr) *	2006-11-20	2008-05-29	Japan Tobacco Inc.	Composé azoté à anneaux fusionnés et son utilisation
US8394792B2 (en) *	2008-03-31	2013-03-12	C&C Research Laboratories	Heterocyclic derivatives
CN102016348B (zh) *	2008-04-28	2016-01-20	罗伯特·博世有限公司	传动带环部件和制造方法及其马氏体时效钢基材

2018
- 2018-05-24 CN CN201880034458.5A patent/CN110691783A/zh active Pending
- 2018-05-24 EP EP18806513.0A patent/EP3632917B1/en active Active
- 2018-05-24 PL PL18806513T patent/PL3632917T3/pl unknown
- 2018-05-24 DK DK21180717.7T patent/DK3909956T3/da active
- 2018-05-24 CA CA3150710A patent/CA3150710C/en active Active
- 2018-05-24 ES ES18806513T patent/ES2907590T3/es active Active
- 2018-05-24 AU AU2018273020A patent/AU2018273020B2/en active Active
- 2018-05-24 WO PCT/KR2018/005932 patent/WO2018217050A1/ko not_active Ceased
- 2018-05-24 TW TW107117713A patent/TWI837089B/zh active
- 2018-05-24 CN CN202111329839.6A patent/CN114085235B/zh active Active
- 2018-05-24 PH PH1/2019/502418A patent/PH12019502418B1/en unknown
- 2018-05-24 CA CA3061301A patent/CA3061301C/en active Active
- 2018-05-24 CN CN202411028089.2A patent/CN119143779A/zh active Pending
- 2018-05-24 IL IL294127A patent/IL294127B2/en unknown
- 2018-05-24 US US16/615,566 patent/US20200207784A1/en not_active Abandoned
- 2018-05-24 HU HUE21180717A patent/HUE070148T2/hu unknown
- 2018-05-24 EP EP21180716.9A patent/EP3909955A1/en active Pending
- 2018-05-24 FI FIEP21180717.7T patent/FI3909956T3/fi active
- 2018-05-24 LT LTEP21180717.7T patent/LT3909956T/lt unknown
- 2018-05-24 NZ NZ758513A patent/NZ758513A/en unknown
- 2018-05-24 MY MYPI2019006799A patent/MY201054A/en unknown
- 2018-05-24 JP JP2020516362A patent/JP2020521007A/ja not_active Withdrawn
- 2018-05-24 EA EA201992801A patent/EA201992801A1/ru unknown
- 2018-05-24 KR KR1020197032941A patent/KR102307504B1/ko active Active
- 2018-05-24 IL IL270789A patent/IL270789B2/en unknown
- 2018-05-24 SI SI201831214T patent/SI3909956T1/sl unknown
- 2018-05-24 HR HRP20250183TT patent/HRP20250183T1/hr unknown
- 2018-05-24 MX MX2019013937A patent/MX393863B/es unknown
- 2018-05-24 TW TW112144614A patent/TW202411234A/zh unknown
- 2018-05-24 ES ES21180717T patent/ES3011357T3/es active Active
- 2018-05-24 PT PT211807177T patent/PT3909956T/pt unknown
- 2018-05-24 NZ NZ780383A patent/NZ780383A/en unknown
- 2018-05-24 EP EP21180717.7A patent/EP3909956B1/en active Active
- 2018-05-24 PL PL21180717.7T patent/PL3909956T3/pl unknown
2019
- 2019-11-21 MX MX2022005722A patent/MX2022005722A/es unknown
- 2019-12-18 ZA ZA2019/08433A patent/ZA201908433B/en unknown
2022
- 2022-06-14 JP JP2022095779A patent/JP7557500B2/ja active Active
- 2022-07-07 US US17/859,603 patent/US12497410B2/en active Active
- 2022-07-07 US US17/859,566 patent/US11866448B2/en active Active
2023
- 2023-09-26 US US18/372,856 patent/US12103938B2/en active Active
- 2023-11-01 US US18/386,093 patent/US12030895B2/en active Active
2024
- 2024-07-10 JP JP2024110729A patent/JP7796815B2/ja active Active
- 2024-07-10 JP JP2024110726A patent/JP2024129160A/ja active Pending
2025
- 2025-11-14 US US19/389,519 patent/US20260070923A1/en active Pending

Also Published As

Publication number	Publication date
EP3632917B1 (en)	2021-11-17
IL270789A (en)	2020-01-30
CA3061301C (en)	2022-05-31
FI3909956T3 (fi)	2025-02-21
HRP20250183T1 (hr)	2025-04-11
JP2020521007A (ja)	2020-07-16
US12103938B2 (en)	2024-10-01
CA3150710A1 (en)	2019-10-23
US20220363691A1 (en)	2022-11-17
IL294127B1 (en)	2024-03-01
JP7796815B2 (ja)	2026-01-09
KR20190132693A (ko)	2019-11-28
EP3909956B1 (en)	2024-12-04
WO2018217050A1 (ko)	2018-11-29
IL270789B2 (en)	2023-09-01
NZ758513A (en)	2022-02-25
US11866448B2 (en)	2024-01-09
MX393863B (es)	2025-03-21
JP2024129161A (ja)	2024-09-26
ES2907590T3 (es)	2022-04-25
TWI837089B (zh)	2024-04-01
US20240083911A1 (en)	2024-03-14
KR102307504B1 (ko)	2021-09-30
IL270789B1 (en)	2023-05-01
JP7557500B2 (ja)	2024-09-27
PT3909956T (pt)	2025-02-21
IL294127B2 (en)	2024-07-01
SI3909956T1 (sl)	2025-04-30
JP2024129160A (ja)	2024-09-26
US20240067659A1 (en)	2024-02-29
US20260070923A1 (en)	2026-03-12
EP3909955A1 (en)	2021-11-17
PH12019502418B1 (en)	2023-12-06
MX2022005722A (es)	2022-06-09
PL3909956T3 (pl)	2025-04-07
AU2018273020A1 (en)	2019-11-14
TW202411234A (zh)	2024-03-16
NZ780383A (en)	2025-12-19
CN114085235B (zh)	2024-08-13
BR112019024253A2 (pt)	2020-06-02
JP2022126729A (ja)	2022-08-30
ZA201908433B (en)	2021-04-28
CN110691783A (zh)	2020-01-14
CA3150710C (en)	2023-10-10
DK3909956T3 (da)	2025-03-03
LT3909956T (lt)	2025-03-10
IL294127A (en)	2022-08-01
CN119143779A (zh)	2024-12-17
EP3632917A4 (en)	2020-07-01
US12030895B2 (en)	2024-07-09
MY201054A (en)	2024-01-31
CA3061301A1 (en)	2019-10-23
CN114085235A (zh)	2022-02-25
US12497410B2 (en)	2025-12-16
US20220340594A1 (en)	2022-10-27
ES3011357T3 (en)	2025-04-07
US20200207784A1 (en)	2020-07-02
EA201992801A1 (ru)	2020-03-19
EP3909956A1 (en)	2021-11-17
PH12019502418A1 (en)	2020-07-06
EP3632917A1 (en)	2020-04-08
HUE070148T2 (hu)	2025-05-28
TW201900652A (zh)	2019-01-01
MX2019013937A (es)	2020-02-07
AU2018273020B2 (en)	2020-10-15

Publication	Publication Date	Title
IL271516A (en)	2020-02-27	method
IL249009B (en)	2019-03-31	A method for making a fused heterocyclic compound
IL274439A (en)	2020-06-30	Process for making Tapinaroff
IL292429B2 (en)	2023-09-01	An improved process for the preparation of aminopyrimidine derivatives
SG11202101919VA (en)	2021-04-29	Manufacturing method for 4-methoxypyrrole derivatives
IL275216A (en)	2020-07-30	A process for the preparation of anthelmintic 4-aminoquinoline-3-carboxamide
SG11201911164WA (en)	2020-01-30	Method for preparing intermediate of 4-methoxypyrrole derivative
ZA202002138B (en)	2021-05-26	Method for preparing oxaspirocycle derivative, and intermediate thereof
GB201703323D0 (en)	2017-04-12	Method for preparing polyols
EP3708567A4 (en)	2021-07-07	PROCESS FOR THE PREPARATION OF A BENZOFURANE DERIVATIVE
IL283331A (en)	2021-07-29	Method for the preparation of n-phenylpyrazole-1-carboxamides
ZA202001475B (en)	2021-07-28	Method for preparing an inhibited starch
EP3630722A4 (en)	2020-10-21	4-METHOXYPYRROLE DERIVATIVE INTERMEDIATE PREPARATION PROCESS
HUE065524T2 (hu)	2024-06-28	Módszer szubsztituált heterociklusos vegyületek elõállítására
ZA201903463B (en)	2022-04-28	Method for preparing hexadecahydropyrene
SG11202004021RA (en)	2020-05-28	Production method for dihydroxyindoles
ZA201802897B (en)	2021-04-28	Preparation method for 2-mercaptobenzothiazole
IL271512B (en)	2022-03-01	A method for the preparation of modified 4-aminoindan derivatives
ZA201604927B (en)	2019-09-25	Aminopyrazolone derivative
IL261229B (en)	2021-06-30	A method for producing a sulfoxide derivative
PT3305790T (pt)	2020-10-19	Método para preparação de um derivado de imidazol e seu intermediário e forma cristalina
IL273639A (en)	2020-05-31	A process for the preparation of pyrrolidine alpha-carboxamide derivatives
IL273695A (en)	2020-05-31	A process for preparing Spiro histories
EP3398959A4 (en)	2019-08-14	METHOD OF PREPARING LIXISENNATIDE
IL263091B (en)	2021-06-30	A method for the production of heterocyclic compounds